|
1
|
Drappatz J, Schiff D, Kesari S, Norden AD
and Wen PY: Medical management of brain tumor patients. Neurol
Clin. 25:1035–1071, ix. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Laquintana V, Trapani A, Denora N, Wang F,
Gallo JM and Trapani G: New strategies to deliver anticancer drugs
to brain tumors. Expert Opin Drug Deliv. 6:1017–1032. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sadowska GB, Chen X, Zhang J, Lim YP,
Cummings EE, Makeyev O, Besio WG, Gaitanis J, Padbury JF, Banks WA
and Stonestreet BS: Interleukin-1β transfer across the blood-brain
barrier in the ovine fetus. J Cereb Blood Flow Metab. 35:1388–1395.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Komarova Y and Malik AB: Regulation of
endothelial permeability via paracellular and transcellular
transport pathways. Annu Rev Physiol. 72:463–493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salama NN, Eddington ND and Fasano A:
Tight junction modulation and its relationship to drug delivery.
Adv Drug Deliv Rev. 58:15–28. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dohgu S, Fleegal-DeMotta MA and Banks WA:
Lipopolysaccharide-enhanced transcellular transport of HIV-1 across
the blood-brain barrier is mediated by luminal microvessel IL-6 and
GM-CSF. J Neuroinflammation. 8:1672011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quest AF, Gutierrez-Pajares JL and Torres
VA: Caveolin-1: An ambiguous partner in cell signalling and cancer.
J Cell Mol Med. 12:1130–1150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun SW, Zu XY, Tuo QH, Chen LX, Lei XY, Li
K, Tang CK and Liao DF: Caveolae and caveolin-1 mediate endocytosis
and transcytosis of oxidized low density lipoprotein in endothelial
cells. Acta Pharmacol Sin. 31:1336–1342. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nag S, Venugopalan R and Stewart DJ:
Increased caveolin-1 expression precedes decreased expression of
occludin and claudin-5 during blood-brain barrier breakdown. Acta
Neuropathol. 114:459–469. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ben Menachem, Zidon O, Ben Menahem Y, Ben
Hur T and Yirmiya R: Intra- hippocampal transplantation of neural
precursor cells with transgenic over- expression of IL-1 receptor
antagonist rescues memory and neurogenesis impairments in an
Alzheimer's disease model. Neuropsychopharmacology.
13:27362013.
|
|
11
|
Hayashi Y, Yoshida Y and Hamada J:
Blood-tumor barrier in malignant brain tumor. No Shinkei Geka.
34:983–999. 2006.(In Japanese). PubMed/NCBI
|
|
12
|
Qin LJ, Xue YX, Gu YT, Zhang ZY, Zhang T
and Sun N: Effect and mechanisms of interleukin-1β in process of
opening the blood-brain barrier by bradykinin. Chinese
Pharmacological Bulletin. 1:58–61. 2012.
|
|
13
|
Allan SM and Rothwell NJ: Cytokines and
acute neurodegeneration. Nat Rev Neurosci. 2:734–744. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davies DC: Blood-brain barrier breakdown
in septic encephalopathy and brain tumours. J Anat. 200:639–646.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Faehling M, Kroll J, Föhr KJ, Fellbrich G,
Mayr U, Trischler G and Waltenberger J: Essential role of calcium
in vascular endothelial growth factor A-induced signaling:
Mechanism of the antiangiogenic effect of carboxyamidotriazole.
FASEB J. 16:1805–1807. 2002.PubMed/NCBI
|
|
16
|
Argaw AT, Asp L, Zhang J, Navrazhina K,
Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, et al:
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in
CNS inflammatory disease. J Clin Invest. 122:2454–2468. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei M, Li H, Huang H, Xu D, Zhi D, Liu D
and Zhang Y: Increased expression of EMMPRIN and VEGF in the rat
brain after gamma irradiation. J Korean Med Sci. 27:291–299. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim J and Jung Y: Different expressions of
AQP1, AQP4, eNOS, and VEGF proteins in ischemic versus non-ischemic
cerebropathy in rats: Potential roles of AQP1 and eNOS in
hydrocephalic and vasogenic edema formation. Anat Cell Biol.
44:295–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lajoie P and Nabi IR: Regulation of
raft-dependent endocytosis. J Cell Mol Med. 11:644–653. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Drab M, Verkade P, Elger M, Kasper M, Lohn
M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, et al:
Loss of caveolae, vascular dysfunction, and pulmonary defects in
caveolin-1 gene-disrupted mice. Science. 293:2449–2452. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhong Y, Smart EJ, Weksler B, Couraud PO,
Hennig B and Toborek M: Caveolin-1 regulates human immunodeficiency
virus-1 Tat-induced alterations of tight junction protein
expression via modulation of the Ras signaling. J Neurosci.
28:7788–7796. 2008. View Article : Google Scholar : PubMed/NCBI
|
